Pharmacology of systemic antifungal agents ESD Ashley, R Lewis, JS Lewis, C Martin, D Andes Clinical infectious diseases 43 (Supplement_1), S28-S39, 2006 | 424 | 2006 |
Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus SA Grim, RP Rapp, CA Martin, ME Evans Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (2 …, 2005 | 127 | 2005 |
Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess Antimicrobial agents and chemotherapy, AAC. 02089-16, 2016 | 110 | 2016 |
Rhabdomyolysis during therapy with daptomycin S Papadopoulos, AM Ball, SE Liewer, CA Martin, PS Winstead, ... Clinical Infectious Diseases 42 (12), e108-e110, 2006 | 92 | 2006 |
Results of an antimicrobial control program at a university hospital C Martin, I Ofotokun, R Rapp, K Empey, J Armitstead, C Pomeroy, ... American Journal of Health-System Pharmacy 62 (7), 732-738, 2005 | 82 | 2005 |
Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness AK Gross, SP Dunn, DJ Feola, CA Martin, R Charnigo, Z Li, A Abdel-Latif, ... Journal of thrombosis and thrombolysis 35 (2), 147-154, 2013 | 74 | 2013 |
Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum sensing CA Martin, AD Hoven, AM Cook European Journal of Clinical Microbiology & Infectious Diseases 27 (8), 635-642, 2008 | 66 | 2008 |
Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome CA Martin, S Roberts, RN Greenberg Clinical Infectious Diseases 35 (7), e78-e81, 2002 | 63 | 2002 |
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance JM Rybak, K Marx, CA Martin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (11 …, 2014 | 56 | 2014 |
Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults AM Cook, C Martin, VR Adams, RS Morehead Antimicrobial agents and chemotherapy 55 (7), 3240-3243, 2011 | 47 | 2011 |
Nephrotoxicity in patients with or without cystic fibrosis treated with polymyxin B compared to colistin RL Crass, WC Rutter, DR Burgess, CA Martin, DS Burgess Antimicrobial agents and chemotherapy 61 (4), e02329-16, 2017 | 43 | 2017 |
Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole D Hayes Jr, AM Ball, HM Mansour, CA Martin, JD Flynn Exp Clin Transplant 9 (6), 399-404, 2011 | 23 | 2011 |
Fulminant invasive pulmonary aspergillosis after a near-drowning accident in an immunocompetent patient KL Ratermann, BJ Ereshefsky, EL Fleishaker, AC Thornton, KP Buch, ... Annals of pharmacotherapy 48 (9), 1225-1229, 2014 | 19 | 2014 |
Utilizing Monte Carlo Simulations to optimize institutional empiric antipseudomonal therapy SJ Tennant, DR Burgess, JM Rybak, CA Martin, DS Burgess Antibiotics 4 (4), 643-652, 2015 | 16 | 2015 |
Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients RZ Thompson, CA Martin, DR Burgess, WC Rutter, DS Burgess Journal of Cystic Fibrosis 15 (5), 660-663, 2016 | 14 | 2016 |
Benefits of a 24-hour inhouse on-call program for pharmacy residents KW Mcconeghy, PS Winstead, AM Cook, CA Martin, KA Weant, JD Flynn American Journal of Health-System Pharmacy 69 (24), 2160-2164, 2012 | 10 | 2012 |
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli BJ Ereshefsky, MN Al-Hasan, Y Gokun, CA Martin Journal of Chemotherapy 29 (1), 30-37, 2017 | 6 | 2017 |
Effect of Clopidogrel Treatment on the Incidence and Severity of Community Acquired Pneumonia: Results of a Five-Year Cohort Study AK Gross, SP Dunn, DJ Feola, CA Martin, SS Smyth Circulation 122 (Suppl 21), A19964-A19964, 2010 | 1 | 2010 |
Syphilis: Here Today...Gone Tomorrow? C Martin Pharmacotherapy Casebook, 11th ed., 2019 | | 2019 |
Erratum for Rutter et al., Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess Antimicrobial agents and chemotherapy 61 (4), 2017 | | 2017 |